Side-by-side comparison of AI visibility scores, market position, and capabilities
Minneapolis water treatment S&P 500 company (NYSE: PNR) at $4.1B 2024 revenue; Q3 2025 at $1.022B (+3%) with 35% US pool market share and $80M transformation savings competing with Hayward and Fluidra for pool equipment.
Pentair plc is a Minneapolis, Minnesota-based (with UK legal domicile) global water treatment company — publicly traded on the New York Stock Exchange (NYSE: PNR) as an S&P 500 component — operating three business segments: Pool (residential and commercial pool equipment), Water Technologies (residential and commercial water treatment), and Flow (industrial water and fluid management). In fiscal 2024, Pentair generated $4.1 billion in revenue with approximately 9,750 employees serving customers in 150+ countries through 127 key distributors and 84 major retailers. In Q3 2025, Pentair reported $1.022 billion in sales (+3% year-over-year) and adjusted EPS of $1.09 (+14%), with $56 million in year-to-date transformation savings tracking toward $80 million for full-year 2025. Pentair holds approximately 35% market share in the US residential pool equipment market. CEO John Stauch has led the company since 2018. Founded 1966.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.